Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metacognitive Therapy for Depression and Generalized Anxiety Disorder in Primary Health Care, Feasibility of a Blended Mediated Treatment

NCT06928428 is registered in ClinicalTrials.gov with Region Stockholm as lead sponsor.

NCT NCT06928428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06928428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metacognitive Therapy for Depression and Generalized Anxiety Disorder in Primary Health Care, Feasibility of a Blended Mediated Treatment
Lead sponsor
Region Stockholm
Phase
Not applicable
Overall status
Enrolling by invitation
Start date
February 10, 2025
Completion date
December 1, 2027
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

depression nos, generalized anxiety disorder